Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092654 8-30 nucleotides targeted to a nucleic acid molecule encoding human Inhibitor-kappa B kinase alpha; gene expression inhibition; antiproliferative, anticancer and antiinflammatory agents
05/15/2003US20030092652 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
05/15/2003US20030092651 Tissue-specific and target RNA-specific ribozymes
05/15/2003US20030092650 Gene expression inhibition; treating developmental disorders or aberrant apoptosis
05/15/2003US20030092649 Antisense modulation of vascular endothelial growth factor receptor-2 expression
05/15/2003US20030092648 Antisense oligonucleotides for gene expression inhibition; antiproliferative agents
05/15/2003US20030092647 Antisense modulation of cholesteryl ester transfer protein expression
05/15/2003US20030092645 Cloning, expression, viral and delivery vectors and hosts
05/15/2003US20030092624 Denaturant (boiling and/or detergent) stable; various uses including de-aggregating and/or preventing aggregation of an aggregating protein such as beta-amyloid or prions, restoring enzyme activity, and immunization using fusion protein
05/15/2003US20030092623 Inducing proliferation of endothelial cells; use of Bv8 antagonists to treat testicular cancer and hormone dependent tumors; Bv8 is a small protein originally isolated from the skin secretions of the frog Bombina variegata
05/15/2003US20030092618 Polypeptides, their production and use
05/15/2003US20030092614 Protein isoform related to sideroflexin 1, named ADPI-41, Alzheimer's disease-Associated Protein Isoform (ADPI); vectors, host cells, antibodies, vaccines; use in the diagnosis, screening, treatment and prophylaxis of AD
05/15/2003US20030092605 Modulators of leukocyte activation, compositions and methods of use
05/15/2003US20030092604 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/15/2003US20030092188 Placental protein 13
05/15/2003US20030092183 Rapid creation of gene targeting vectors using homologous recombination in yeast
05/15/2003US20030092182 Apparatus for use in the transfer of nucleotide sequences in to cells
05/15/2003US20030092181 Cell transfection apparatus and methods for making and using the cell transfection apparatus
05/15/2003US20030092180 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
05/15/2003US20030092179 Expression vector for use as gene transfer tool in genetic engineering
05/15/2003US20030092177 Preparing preferential cells from mononucler cells in culture; obtain monocytes, incubate with interferon, recover preferental cells
05/15/2003US20030092175 Polypeptide for use as pharmaceuticals or as antigens for preparing antibodies against preferential polypeptides
05/15/2003US20030092172 Device for use in circulating a carrier fluid during nucleotide sequence amplification
05/15/2003US20030092168 Generation of extract rich in plant nucleic acids; obtain plant materia, incubate with cellulase, obtain lysate, extract nucleotide sequences
05/15/2003US20030092164 Polypeptide use in the treatment of cell proliferative disorders
05/15/2003US20030092162 Chimeric adenoviral vector for use as gene transfer tool
05/15/2003US20030092161 Compositions and methods for production of recombinant viruses, and uses therefor
05/15/2003US20030092160 Genetically engineered cell for use in the generation of vaccines against bacterial and viral infections
05/15/2003US20030092158 Phosphorothioate antisense heparanase oligonucleotides
05/15/2003US20030092157 Compositions, screening systems and methods for modulating HDL cholesterol and triglyceride levels
05/15/2003US20030092155 Modified phytases
05/15/2003US20030092147 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092144 Production of farnesol and geranylgeraniol
05/15/2003US20030092143 Enzyme for use in the generation of vanillin
05/15/2003US20030092138 Process for the preparation of D-pantothenic acid and/or salts thereof
05/15/2003US20030092137 Process for the preparation of L-amino acids by using coryneform bacteria
05/15/2003US20030092135 For improving sensitivity and specificity of polynucelotide synthesis via controlling target specific primer extension through all stages of DNA or RNA amplification; genetic engineering
05/15/2003US20030092134 Nucleic acid encoding 3'-5' exonuclease of bacteriophage RM 378
05/15/2003US20030092133 Interleukins-21 and 22
05/15/2003US20030092131 Isolation of bovine chymosin and human tissue plasminogen activator and signal polypeptides from Trichoderma cellobiohydrolase I and II; gene expression; genetic engineering
05/15/2003US20030092130 DNA encoding polypeptides having interferon-gamma inducing activity
05/15/2003US20030092129 Nervous system polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030092128 Nucleotide squences coding polypeptide for use in the textile and fabric treatment
05/15/2003US20030092125 Biasing the immune response of mammal; obtain phage display antibody library, recover peptide from library which binds specific antibody, immunize mammal
05/15/2003US20030092122 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
05/15/2003US20030092115 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092113 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092112 Novel nucleic acids and polypeptides
05/15/2003US20030092111 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092108 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092107 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092106 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092105 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092104 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092103 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092101 Human tumor necrosis factor receptors TR13 and TR14
05/15/2003US20030092100 Tn7 transposition method for producing mutant genes
05/15/2003US20030092099 Genetic engineering; for production of enzymes, growth factors, cytokines, immunogenic proteins, and immunoglobulin proteins
05/15/2003US20030092097 Enzymatic polypeptide for use in the treatment of taxtiles and fabric
05/15/2003US20030092095 Screening, diagnostic and therapeutic methods relating to RIZ
05/15/2003US20030092094 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
05/15/2003US20030092084 EBV-infected stomach cancer cell line
05/15/2003US20030092079 Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions
05/15/2003US20030092073 Method for sequence specific biotinylation
05/15/2003US20030092072 Rapid methods for identifying modifiers of cellular apoptosis activity
05/15/2003US20030092070 Genetic construct intracellular monitoring system
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092065 Peptide for use in the treatment and prevention of allergies
05/15/2003US20030092062 Immobilizing biological molecules
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092057 Detection of ligands for preferential polypeptides; obtain sample, incubate with ligand sample, detect bound ligand
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092051 Pyrophosphorolysis activated polymerization (PAP): application to allele-specific amplification and nucleic acid sequence determination
05/15/2003US20030092045 Binding nucleotide sequences to cellulose; obtain cellulose, mix with solution, adjust sample and polyethylene glycol concentration, recover bound nucleotide sequenes
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030092043 Melanoma differentiation associated gene - 5 and promoter and uses thereof
05/15/2003US20030092042 Diagnosing cancer in mammals; obtain tissue sample, extract nucleotide sequences, detect galinin gene, determine copy number for gene, compare to control, amplified copy number indicates cancer
05/15/2003US20030092038 Genes for Niemann-Pick type C disease
05/15/2003US20030092035 Nucleotide sequences coding polypeptide for use in the treatment of pain
05/15/2003US20030092033 Methods for the Manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes
05/15/2003US20030092032 Reporter gene construct for the detection of HIV Rev and HIV Tat
05/15/2003US20030092031 Methods for the detection, analysis and isolation of nascent proteins
05/15/2003US20030092030 Wit 3.0, a novel gene to control soft tissue wound healing
05/15/2003US20030092028 Diagnosing insulin resistance in mammals; obtain fluid sample, detect insulin resistant marker, compare to control, amplified concentration of marker indicates insulin resistant
05/15/2003US20030092026 Nucleotide sequences coding polypeptide for use biosynthesis of methionine; for use in preparation of animal feeds
05/15/2003US20030092025 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment, prevention of tumor disorders
05/15/2003US20030092024 Essential bacterial genes and their use
05/15/2003US20030092023 Adjustment of nucleotide sequences; obtain nucleotide sequences, fragment, incubate with templates, propagate recover nuceotide sequences
05/15/2003US20030092018 Cloned DNA polymerases from thermotoga neapolitana
05/15/2003US20030092014 Nucleotide sequences coding polypeptide for use in the generation of stress, disease and drought resistant plants
05/15/2003US20030092011 Human cDNAs and proteins and uses thereof
05/15/2003US20030092010 Regulation of gene expression in cells; obtain cells, transform with vector coding preferential genes, incubate cells with ligand, monitor reporter gene expression, monitor formation of binding complexes
05/15/2003US20030092007 Clone-array pooled shotgun strategy for nucleic acid sequencing
05/15/2003US20030092006 Classification of preferential nucleotide sequences; obtain nucleotide sequences, insert into vector, transform cells, generate clones, generate ribonucleic acid from clones, divide sequences, amplify and measure sequence concentration
05/15/2003US20030092005 Sequences determination of preferential nucleotide sequences; obtain nucleotide sequences, denatrue, incubate with primers and polymerases, amplify, recover products, determine nucleotide sequence of sample
05/15/2003US20030092003 Nucleic acid sensor molecule which modulates expression of amyloid precursor proteins cleaving enzyme; for use in the treatment of nervous system disorders
05/15/2003US20030092001 Nucleic acid molecules encoding multiple start codons and histidine tags